In the press

VIRONTAR N: Obras Sociales with 100% reimbursement

READ MORE

Antituberculosis drug developed by CONICET together with Richmond also receives patent in Europe.

The new TB antimicrobial, developed by researchers and fellows of CONICET together with Laboratorios Richmond, obtained last February the Patent in the US and now received another of the European Patent Office (EPO).
READ MORE

Richmond invests in Colombia

Laboratorios Richmond signed an investment agreement with Colombian Laboratorios Expofarma, with the objective of increasing and developing present operations both in Colombia and other markets where both companies currently commercialize their line of products.
READ MORE

New anti microbial developed by Conicet researchers together with Laboratorios Richmond is patented in the US

The new anti microbial for tuberculosis’ treatment, developed by Conicet specialists together with Laboratorios Richmond, has been patented by the US Patent and Trademark Office.
READ MORE

The Health Ministry acquires the first 89.600 units of Probirase

More than 60% of the 140.000 Sofosbuvir units the health ministry bought, correspond to Richmond’s product. Its more accessible price allows for a higher number of infected Hepatitis C patients in a critic state to receive the treatment.
READ MORE

Financial contributions in support of national scholarship program

As part of its 80th year anniversary celebrations, Laboratorios Richmond has decided to encourage and promote college education by donating funds to the national program “Becas de Ayuda Económica Dr. Manuel Sadosky", for students in need of financial aid at Universidad de Buenos Aires’ Faculty of Natural and Exact Sciences.
READ MORE

Probirase®: Increased accessibility with high quality for the Hepatitis C treatment

It’s the first Sofosbuvir generic in the region. The drug, combined with others in the treatment of the Hepatitis C virus, presents very high rates of efficacy.
READ MORE

Cerebrolisina, la droga de la esperanza: ACV, esa enfermedad

Tanto en nuestro país como en el resto del mundo hay un evento cerebrovascular cada 4 minutos. ¿Cómo ocurren? ¿Son prevenibles? Los factores de riesgo y las chances de recuperación. Un medicamento permite ser optimistas.
READ MORE